A cannabis-derived compound reduced HIV drug-induced nerve pain in mice through CB2 receptors
Beta-caryophyllene, a CB2-selective phytocannabinoid found in cannabis, prevented and reduced nerve pain caused by the HIV drug zalcitabine in mice without activating the psychoactive CB1 receptor.
Quick Facts
What This Study Found
Beta-caryophyllene (BCP) prevented the development of mechanical allodynia when co-administered with the NRTI zalcitabine and attenuated established pain through CB2 receptor activation. A CB2 antagonist (AM 630) blocked the pain-relieving effect, while a CB1 antagonist (AM 251) did not, confirming the CB2-specific mechanism. BCP also reduced inflammatory cytokines in paw skin and brain.
Key Numbers
5 days of zalcitabine treatment induced mechanical allodynia. BCP reduced cytokine transcripts (IL-1beta, TNF-alpha, IFN-gamma) in both paw skin and brain. AM 630 (CB2 antagonist) blocked BCP effects. AM 251 (CB1 antagonist) did not.
How They Did This
Controlled animal study using female BALB/c mice treated with zalcitabine (ddC) for 5 days to induce neuropathic pain. BCP, minocycline, or pentoxifylline were co-administered. CB1 and CB2 receptor antagonists were used to determine mechanism. Cytokine transcripts and Erk1/2 phosphorylation were measured.
Why This Research Matters
HIV-associated neuropathic pain responds poorly to available drugs. While smoked cannabis has shown benefit in clinical trials, the psychoactive effects of CB1 activation limit its use. BCP offers a potential alternative that targets pain through CB2 without psychoactive side effects.
The Bigger Picture
Beta-caryophyllene is found in many plants beyond cannabis, including black pepper and cloves. If it can address neuropathic pain through CB2 without CB1-related side effects, it could offer a non-psychoactive cannabinoid-based treatment option for HIV patients.
What This Study Doesn't Tell Us
Mouse model of neuropathic pain may not fully represent the human condition. Only female mice were used. The NRTI tested (zalcitabine) is no longer commonly used in HIV treatment. Doses may not translate directly to humans.
Questions This Raises
- ?Would BCP work for neuropathic pain caused by currently used HIV medications?
- ?Does the anti-inflammatory mechanism translate to human nerve tissue?
- ?What dose would be needed for clinical efficacy?
Trust & Context
- Key Stat:
- CB2-specific, no psychoactive effects
- Evidence Grade:
- Rated preliminary because this is an animal study using a single NRTI in one mouse strain.
- Study Age:
- Published in 2019. The tested NRTI (zalcitabine) is largely obsolete, but the CB2 pain mechanism may apply to other causes of neuropathy.
- Original Title:
- β-Caryophyllene, a CB2-Receptor-Selective Phytocannabinoid, Suppresses Mechanical Allodynia in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.
- Published In:
- Molecules (Basel, Switzerland), 25(1) (2019)
- Authors:
- Aly, Esraa(2), Khajah, Maitham A, Masocha, Willias(3)
- Database ID:
- RTHC-01910
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is beta-caryophyllene?
It is a terpene found in cannabis, black pepper, cloves, and other plants. It selectively activates CB2 cannabinoid receptors without the psychoactive effects associated with CB1 activation.
Could this help with other types of nerve pain?
Potentially. The CB2-mediated anti-inflammatory mechanism could apply to other neuropathic pain conditions, but this study only tested one specific cause (NRTI-induced neuropathy).
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
- thc-and-painkillers-opioid-interactions
- thc-and-muscle-relaxers-combining
- thc-and-ibuprofen-safe-combine-research
- cannabis-and-arthritis-research
Cite This Study
https://rethinkthc.com/research/RTHC-01910APA
Aly, Esraa; Khajah, Maitham A; Masocha, Willias. (2019). β-Caryophyllene, a CB2-Receptor-Selective Phytocannabinoid, Suppresses Mechanical Allodynia in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.. Molecules (Basel, Switzerland), 25(1). https://doi.org/10.3390/molecules25010106
MLA
Aly, Esraa, et al. "β-Caryophyllene, a CB2-Receptor-Selective Phytocannabinoid, Suppresses Mechanical Allodynia in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.." Molecules (Basel, 2019. https://doi.org/10.3390/molecules25010106
RethinkTHC
RethinkTHC Research Database. "β-Caryophyllene, a CB2-Receptor-Selective Phytocannabinoid, ..." RTHC-01910. Retrieved from https://rethinkthc.com/research/aly-2019-caryophyllene-a-cb2receptorselective-phytocannabinoid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.